| Research on YTS109 Cell in Patients With Recurrent/Refractory Autoimmune Hemolytic Anemia (NCT07453836) | China Immunotech (Beijing) Biotechnology Co., Ltd. | 2026-03-18 |
| An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases (NCT07236762) | China Immunotech (Beijing) Biotechnology Co., Ltd. | 2025-11-24 |
| Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases (NCT07236801) | China Immunotech (Beijing) Biotechnology Co., Ltd. | 2025-11-13 |
| A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases (NCT07123519) | China Immunotech (Beijing) Biotechnology Co., Ltd. | 2025-08-13 |
| A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases (NCT07104721) | China Immunotech (Beijing) Biotechnology Co., Ltd. | 2025-08-04 |
| A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases (NCT06978647) | China Immunotech (Beijing) Biotechnology Co., Ltd. | 2025-05-19 |
| A Clinical Study of YTS109 Cell in R/R Systemic Lupus Erythematosus (NCT06943937) | China Immunotech (Beijing) Biotechnology Co., Ltd. | 2025-04-16 |
| A Study of YTS109 Cell in Subjects With Relapsed/Refractory Autoimmune Hemolytic Anemia (NCT07075484) | China Immunotech (Beijing) Biotechnology Co., Ltd. | 2025-01-15 |
| An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease (NCT06379646) | China Immunotech (Beijing) Biotechnology Co., Ltd. | 2024-04-24 |